
Dr Sanjeev Kumar Chaudhary
@skchaudhary333
MD Medicine, DM Cardiology,
Consultant Interventional Cardiologist
ID: 1342342199388766208
25-12-2020 05:31:56
21 Tweet
635 Followers
3,3K Following








📢 New pharmacological agents and novel CV #pharmacotherapy strategies in 2023: an updated review of the latest evidence for practice bit.ly/49NUOqr EHJ-CVP Editor-in-Chief Felice Gragnano Juan Carlos Kaski Erik Lerkevang Grove #CardioX #Cardiology #ESCYoung #EHJPharmacotherapy 💊




#EAPCI/PCR Journal Club: PCI versus #CABG in patients with left main disease with and without #diabetes ➡️pcronline.com/PCR-Publicatio… Antonio Colombo and Alessandro Sticchi review ✍️ this pooled analysis of 4 RCTs that shows that diabetic patients undergoing revascularization face



Therapy duration and improvement of ventricular function in de novo heart failure. Read the result of the Heart Failure Optimization study in #EHJ. doi.org/10.1093/eurhea… #HF #EF #Therapy #cardiotwitter European Society of Cardiology Journals European Society of Cardiology



🔥#ESC2024 SUCCOUR-MRI shows benefit of GLS-guided cardioprotection in patients treated w anthracyclines🔥 🔥Congratulations and 🙏Tom Marwick dineshpmcc & team! Time to add GLS European Society of Cardiology #CardioOnc risk stratification? European Society of Cardiology Journals Teresa López Fdez



A study just published in #EHJ explored the effect on long-term survival of coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy. Read more 👉 bit.ly/4hEAIU3 Rocco Montone EHJ Editor-in-Chief

